Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Effectiveness of IL-5/5Ra Targeted Biologics in Severe Eosinophilic Asthma With Comorbid Bronchiectasis.
Bendien SA, Kroes JA, van Hal LHG, Braunstahl GJ, Broeders MEAC, Oud KTM, Patberg KW, Smeenk FWJM, van Veen IHPAA, Weersink EJM, Fieten KB, Hashimoto S, van Veen A, Sont JK, van Huisstede A, van de Ven MJT, Langeveld B, Maitland-van der Zee AH, Ten Brinke A; Registry of Adult Patients With Severe Asthma for Optimal Disease Management Team. Bendien SA, et al. Among authors: van veen a. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2724-2731.e2. doi: 10.1016/j.jaip.2023.05.041. Epub 2023 Jun 7. J Allergy Clin Immunol Pract. 2023. PMID: 37295671
Anti-IL-5/5Ra biologics improve work productivity and activity in severe asthma: a RAPSODI registry-based cohort study.
van der Valk JPM, Hekking PP, Rauh SP, Patberg KW, van Veen IA, Van Huisstede A, Smeenk FWJM, van de Ven MJT, Broeders MEAC, Hilvering B, van Exsel J, Oud KTM, Langeveld B, Fieten KB, van Veen A, Hashimoto S, Sont JK, Ten Brinke A, Braunstahl GJ; RAPSODI Team. van der Valk JPM, et al. Among authors: van veen a. J Asthma. 2023 Oct;60(10):1869-1876. doi: 10.1080/02770903.2023.2196563. Epub 2023 Apr 21. J Asthma. 2023. PMID: 36976568
Long-Term Weight Changes After Starting Anti-IL-5/5Ra Biologics in Severe Asthma: The Role of Oral Corticosteroids.
Ten Have L, Visser E, Meulmeester FL, Bendien SA, Braunstahl GJ, Broeders MEAC, Fieten KB, Hashimoto S, van Huisstede A, Langeveld B, Oud KTM, Patberg KW, Smeenk FWJM, van Veen A, van Veen IH, van de Ven MJT, Weersink EJM, de Jong K, Sont JK, Kroes JA, Ten Brinke A. Ten Have L, et al. Among authors: van veen a. J Allergy Clin Immunol Pract. 2023 Sep;11(9):2748-2756.e3. doi: 10.1016/j.jaip.2023.06.054. Epub 2023 Jul 1. J Allergy Clin Immunol Pract. 2023. PMID: 37399945 Free article.
Induction of Cure in Early Arthritis (I CEA): study protocol for an investigator-initiated randomized single-blind clinical trial with open-label extension to compare three treatment strategies in patients with newly diagnosed undifferentiated arthritis.
Bergstra SA, van Ouwerkerk L, Nevins IS, van der Pol JA, Helmich GS, Hest I, van Veen A, Bos R, Goekoop-Ruiterman YPM, Vonkeman HE, Bijsterbosch J, de Jong PHP, Güler-Yüksel M, Böhringer S, Huizinga TWJ, van Gaalen FA. Bergstra SA, et al. Among authors: van veen a. Trials. 2024 Nov 13;25(1):758. doi: 10.1186/s13063-024-08609-5. Trials. 2024. PMID: 39533416 Free PMC article.
Regional variation in the interpretation of contact precautions for multi-drug-resistant Gram-negative bacteria: a cross-sectional survey.
van Veen A, de Goeij I, Damen M, Huijskens EGW, Paltansing S, van Rijn M, Bentvelsen RG, Veenemans J, van der Linden M, Vos MC, Severin JA; Infection Prevention and Antimicrobial Resistance Care Network South-western Netherlands. van Veen A, et al. J Hosp Infect. 2024 Oct;152:1-12. doi: 10.1016/j.jhin.2024.06.020. Epub 2024 Jul 26. J Hosp Infect. 2024. PMID: 39069006 Free article.
Contact investigations for antibiotic-resistant bacteria: a mixed-methods study of patients' comprehension of and compliance with self-sampling requests post-discharge.
van Veen A, Lescure DLA, Verhaegh SJC, de Goeij I, Erasmus V, van Beeck EF, Tjon-A-Tsien A, Splinter J, Christiaanse JC, Damen M, Huijskens EGW, Paltansing S, van Rijn M, Veenemans J, Vos MC, Severin JA; Infection Prevention and Antimicrobial Resistance Care Network South-western Netherlands. van Veen A, et al. Antimicrob Resist Infect Control. 2023 Aug 10;12(1):77. doi: 10.1186/s13756-023-01277-1. Antimicrob Resist Infect Control. 2023. PMID: 37563633 Free PMC article.
A History of Regulatory Animal Testing: What Can We Learn?
Swaters D, van Veen A, van Meurs W, Turner JE, Ritskes-Hoitinga M. Swaters D, et al. Among authors: van veen a. Altern Lab Anim. 2022 Sep;50(5):322-329. doi: 10.1177/02611929221118001. Epub 2022 Aug 19. Altern Lab Anim. 2022. PMID: 35983829 Free article.
Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma - First Initiators and Switchers.
Hashimoto S, Kroes JA, Eger KA, Mau Asam PF, Hofstee HB, Bendien SA, Braunstahl GJ, Broeders MEAC, Imming LM, Langeveld B, Maitland-van der Zee AH, Oud KTM, Patberg KW, Smeenk FWJM, Romme EAPM, van Bezouw MJ, van de Ven MJ, van Veen A, van Velzen E, van Veen IHPAA, Weersink EJM, Ten Brinke A, Sont JK, Bel EH; RAPSODI team. Hashimoto S, et al. Among authors: van veen a. J Allergy Clin Immunol Pract. 2022 Aug;10(8):2099-2108.e6. doi: 10.1016/j.jaip.2022.04.014. Epub 2022 Apr 26. J Allergy Clin Immunol Pract. 2022. PMID: 35487369 Free article.
63 results